Skip to main content
SpringerLink
Log in

Pharmacological Prevention of Arrhythmic Recurrences

  • Conference paper
Book cover Emerging Pathologies in Cardiology

  • 451 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fuster V, Gibbons RJ (2001) ACC AHA/ESC: Guidelines for the management of patients with atrial fibrillation. Eur Heart J 22:1852–1923

    Article  PubMed  CAS  Google Scholar 

  2. Boriani G, Biffi M, Branzi A (1998) Pharmacological treatment of atrial fibrillation: a review of prevention of recurrences and control of ventricular response. Arch Gerontol Geriatr 27:127–139

    Article  CAS  Google Scholar 

  3. Alessie MA (1998) Atrial electrophysiologic remodeling: another vicious circle. J Cardiovasc Elettrophysiol 9:1378–1393

    Google Scholar 

  4. Verhorst PMJ, Kamp O, Welling RC (2001) Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation. Am J Cardiol 79:1235–1239

    Google Scholar 

  5. Mattioli AV, Vivoli D, Bastia E (1997) Doppler echocardiographic parameters predictive of recurrence of atrial fibrillation of different etiologic origins. J Ultrasound Med 16:695–698

    PubMed  CAS  Google Scholar 

  6. Deedwania PC, Singh BN, Ellenbogen K et al (1998) Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observation from the Veterans Affairs Congestive Heart Failure Survival Trial of Anti-arrhythmic Therapy (CHF-STAT). Circulation 98:2574–2579

    PubMed  CAS  Google Scholar 

  7. Anderson JL, Gilbert EM, Alpbert PL et al (1989) Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating anti-arrhythmic therapy. A multicenter double-blind crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. Circulation 80:1557–1570

    PubMed  CAS  Google Scholar 

  8. Pietersen H, Hellemann H (1991) Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. Am J Cardiol 67:713–717

    Article  PubMed  CAS  Google Scholar 

  9. Carelli G, Dorian P (1996) Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. Am J Cardiol 77:53A–59A

    Article  Google Scholar 

  10. Van Wijklm, Den Heijr P (1989) Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation. J Cardiovasc Pharmacol 13:32–36

    Google Scholar 

  11. Van Gelder IC, Crijnshj (1989) Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 64:1317–1321

    Article  PubMed  Google Scholar 

  12. Lee Sh, Chen S, Chiang CE et al (1996) Comparison of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial. J Intern Med 239:253–260

    Article  PubMed  CAS  Google Scholar 

  13. Reinol SC, Cantillon CO (1993) Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 79:1198–1202

    Google Scholar 

  14. Alboni P, Botto GL (2005) Out of hospital treatment of recent onset atrial fibrillation with the “pill in the pocket” approach. N Engl J Med (in press)

    Google Scholar 

  15. Kochiadakis GE, Igoumenidis NE, Marketou ME et al (2000) Low dose amiodarone and sotalol in the treatment of recurrent symptomatic atrial fibrillation: comparative placebo controlled study. Heart 84:251–257

    Article  PubMed  CAS  Google Scholar 

  16. Roy D, Talajic M (2000) Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913–920

    Article  PubMed  CAS  Google Scholar 

  17. Vitolo E, Tronci M, La Rovere M (1981) Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. Acta Cardiol 36: 431–434

    PubMed  CAS  Google Scholar 

  18. Vorperian VR, Havighurst TC (1997) Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30:791–798

    Article  PubMed  CAS  Google Scholar 

  19. Sing S, Zoble RG (2000) Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study. Circulation 102:2385–2390

    Google Scholar 

  20. Greenbaum RA, Campbell TJ (1998) Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide: DE EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) study. Circulation 98:1663–1671

    Google Scholar 

  21. Kuhlkamp V, Schirdewan A, (2000) Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation. A randomized doubleblind placebo-controlled study. J Am Coll Cardiol 36:139–146

    Article  PubMed  CAS  Google Scholar 

  22. Lucio E, Flores A (2003) Effectiveness of metoprolol in prevention of atrial fibrillation and flutter in the postoperative period of coronary artery by-pass graft surgery. Arq Bras Cardiol 82:42–46

    Google Scholar 

  23. Toboul P, Brugada, Capucci A (2003) Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 24:1481–1487

    Article  Google Scholar 

  24. Rossiem Lown B (1967) The use of quinidine in cardioversion. Am J Cardiol 19:234–238

    Article  Google Scholar 

  25. Cappucci A, Villani GQ, Aschieri D (2000) Oral amiodarone increases the efficacy of direct current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 21:66–73

    Article  Google Scholar 

  26. Botto GL, Belotti G, Ciro A, on behalf of the VERAF study group (2002) Verapamil in prevention of early recurrence of atrial fibrillation: final results of the VERAF study. Eur Heart J 23:660

    Google Scholar 

  27. De Simone A, De Pasquale M, De Matteis C, on behalf of the VEPARAF study (2003) Verapamil class antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). Eur Heart J 24: 1425–1429

    Article  PubMed  Google Scholar 

  28. Madrid AH, Bueno MG (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomized study. Circulation 106:16

    Article  Google Scholar 

  29. Chiaranda G, Cavarra ML, Busacca G (2004) The role of candesartan in the maintenance of sinus rhythm in patient with atrial fibrillation lasting > 48 h, Italian Heart J, 5(Suppl 5):C108

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Coronary Care Unit, Muscatello Hospital, Augusta (Syracuse)

    G. Chiaranda, M.L. Cavarra, C.L. Romeo & M. Chiaranda

  2. Coronary Care Unit, Ferrarotto University Hospital, Catania, Italy

    T. Regolo

Authors
  1. G. Chiaranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.L. Cavarra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C.L. Romeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Chiaranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Regolo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiology Division, S. Luigi — S.Currò Hospital, Catania, Italy

    M. M. Gulizia MD (Chief) (Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Italia

About this paper

Cite this paper

Chiaranda, G., Cavarra, M., Romeo, C., Chiaranda, M., Regolo, T. (2005). Pharmacological Prevention of Arrhythmic Recurrences. In: Gulizia, M.M. (eds) Emerging Pathologies in Cardiology. Springer, Milano . https://doi.org/10.1007/88-470-0341-5_12

Download citation

  • DOI: https://doi.org/10.1007/88-470-0341-5_12

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0311-8

  • Online ISBN: 978-88-470-0341-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation